ISCC (Indonesian Journal of Cancer Chemoprevention) (Aug 2021)

Bone Resorption in Ameloblastoma and Its Underlying Mechanism

  • Jackson Jackson,
  • Johni Halim,
  • Rezky Anggraeni,
  • Ferry Sandra

DOI
https://doi.org/10.14499/indonesianjcanchemoprev12iss1pp57-66
Journal volume & issue
Vol. 12, no. 1
pp. 57 – 66

Abstract

Read online

Ameloblastoma, a tumor located in the jaw, grows slowly but locally invasive. Ameloblastoma expands in the jaw based on a mechanism resorbing the surrounding bone. To date, the bone resorption mechanisms of ameloblastoma are associated with the expression of receptor activator of nuclear factor (NF)-κB (RANK) ligand (RANKL), matrix metalloproteinases (MMPs), and tumor necrosis factor (TNF)-α. RANKL plays an important role in generating osteoclastogenesis. MMPs degrade the extracellular matrix. TNF-α can induce the formation of osteoclast and modulate the MMPs. In this review the bone resorption mechanism of ameloblastoma as well its signaling pathway will be disclosed. Keywords: Ameloblastoma, RANKL, MMPs, TNF-α.